Janone welcomes john bonfiglio -- veteran biotech executive, deal maker and strategist -- to top management team

Bonfiglio is known for raising capital, building start-ups, and leading successful biotech companies as ceo and coo.      las vegas , march 23, 2023 /prnewswire/ -- janone (nasdaq: jan), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, announced the hiring of john n.
JAN Ratings Summary
JAN Quant Ranking